EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 229 filers reported holding EDITAS MEDICINE INC in Q4 2019. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $17,000 | -61.9% | 920 | -15.4% | 0.00% | -50.0% |
| Q3 2021 | $44,654 | -27.5% | 1,087 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $61,568 | +777.8% | 1,087 | +550.9% | 0.00% | – |
| Q1 2021 | $7,014 | -53.9% | 167 | -23.0% | 0.00% | -100.0% |
| Q4 2020 | $15,214 | +224.7% | 217 | +29.9% | 0.00% | – |
| Q3 2020 | $4,686 | -5.1% | 167 | 0.0% | 0.00% | – |
| Q2 2020 | $4,940 | +49.2% | 167 | 0.0% | 0.00% | – |
| Q1 2020 | $3,312 | -33.0% | 167 | 0.0% | 0.00% | – |
| Q4 2019 | $4,945 | +30.2% | 167 | 0.0% | 0.00% | – |
| Q3 2019 | $3,798 | -8.1% | 167 | 0.0% | 0.00% | – |
| Q2 2019 | $4,132 | +1.2% | 167 | 0.0% | 0.00% | – |
| Q1 2019 | $4,083 | -86.8% | 167 | -80.7% | 0.00% | -100.0% |
| Q2 2018 | $30,993 | -4.9% | 865 | -12.0% | 0.00% | 0.0% |
| Q1 2018 | $32,586 | +7.9% | 983 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $30,208 | +28.0% | 983 | 0.0% | 0.00% | +33.3% |
| Q3 2017 | $23,602 | – | 983 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |